Archives for: April 23rd, 2015

CorMedix Presents Data from Neutrolin® Post Marketing Surveillance Study At Two Medical Conferences

Written by Welcome on April 23, 2015

BEDMINSTER, N.J., April 23, 2015 /PRNewswire/ — CorMedix Inc. (NYSE MKT: CRMD), a…

CorMedix Institutes Program to Reduce Neutrolin® Cost of Goods; Reports on Strategic Review Process Managed by Evercore

Written by Welcome on April 9, 2015

BEDMINSTER, N.J., April 9, 2015 — CorMedix Inc. (NYSE MKT: CRMD),…